title: Cetuximab-induced pneumonitis in head and neck cancer patient.
authors.forename: F Y F L
authors.initials: FY
authors.lastname: De Vos
authors.forename: C M L
authors.initials: CM
authors.lastname: Driessen
authors.forename: H C J
authors.initials: HC
authors.lastname: Jaspers
authors.forename: C M L
authors.initials: CM
authors.lastname: van Herpen
authors.forename: B
authors.initials: B
authors.lastname: Simons
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy; D000068818:Cetuximab; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D011014:Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011859:Radiography; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab